RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:QuestionsNot sure how this topic has gained so much traction. What should headline is the fact that corporate & operating espenses combined are a whopping 96.7% of revenue thus far. This is a staggering figure and one that is unlikley to abate any time soon with M&A season upon us.
Lastly, someone here mentioned that the yet to be acquired Arizona Vein was doing 6million in ebitda. This is sloppy and or misleading reporting. It is imprtnat to distinguish between adjusted ebitda ( the kind that adds back very real, recurring expenditures) and actual ebitda. it is of little suprise that this house of mirrors adheres to the former.